The Leukemia & Lymphoma Society: Screen to Lead Program

The goal of this RFA is two‐fold: to support the discovery of lead compounds/biologics through high‐ throughput screening (HTS) and to drive the development of small molecules toward in vivo proof of concept studies in disease relevant animal models for hematological malignancies.

Funding: up to $1,000,000for a 2 years including overhead.

http://www.lls.org/research/screen-to-lead-program?src1=22051&src2